5/30
03:58 pm
ctlt
Catalent (NYSE:CTLT) investors are sitting on a loss of 47% if they invested three years ago [Yahoo! Finance]
Neutral
Report
Catalent (NYSE:CTLT) investors are sitting on a loss of 47% if they invested three years ago [Yahoo! Finance]
5/29
09:24 am
ctlt
Catalent Stockholders Approve Transaction with Novo Holdings [Yahoo! Finance]
Low
Report
Catalent Stockholders Approve Transaction with Novo Holdings [Yahoo! Finance]
5/29
09:07 am
ctlt
Catalent Stockholders Approve Transaction with Novo Holdings
Low
Report
Catalent Stockholders Approve Transaction with Novo Holdings
5/29
01:16 am
ctlt
Catalent, Inc. (NYSE: CTLT) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Low
Report
Catalent, Inc. (NYSE: CTLT) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
5/28
12:57 pm
ctlt
Tim Scott to Succeed Joe Panetta as Biocom California President and CEO [Yahoo! Finance]
Low
Report
Tim Scott to Succeed Joe Panetta as Biocom California President and CEO [Yahoo! Finance]
5/27
04:06 am
ctlt
Clinical Trial Supply and Logistics for Pharma market is projected to grow at a CAGR of 9.3% by 2034: Visiongain [Yahoo! Finance]
Medium
Report
Clinical Trial Supply and Logistics for Pharma market is projected to grow at a CAGR of 9.3% by 2034: Visiongain [Yahoo! Finance]
5/21
03:04 am
ctlt
Catalent, Inc. (NYSE: CTLT) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Low
Report
Catalent, Inc. (NYSE: CTLT) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
5/16
11:18 am
ctlt
Pharmaceutical Contract Packaging Market Size Expected to Reach USD 36.11 Bn by 2032 [Yahoo! Finance]
Low
Report
Pharmaceutical Contract Packaging Market Size Expected to Reach USD 36.11 Bn by 2032 [Yahoo! Finance]
5/15
09:25 am
ctlt
Cell and Gene Therapy Manufacturing Research Report 2024 [Yahoo! Finance]
Low
Report
Cell and Gene Therapy Manufacturing Research Report 2024 [Yahoo! Finance]
5/14
10:44 pm
ctlt
Drug Discovery Outsourcing Market size is set to grow by USD 1.79 bn from 2024-2028, robust demand for biosimilars to boost the market growth, Technavio [Yahoo! Finance]
Low
Report
Drug Discovery Outsourcing Market size is set to grow by USD 1.79 bn from 2024-2028, robust demand for biosimilars to boost the market growth, Technavio [Yahoo! Finance]
5/14
10:41 am
ctlt
$19.81 Billion Large Molecule Drug Substance Contract Development and Manufacturing Organization (CDMO) Market Analysis - Global Industry Size, Share, Trends, Opportunity & Forecast, 2019-2029F [Yahoo! Finance]
Low
Report
$19.81 Billion Large Molecule Drug Substance Contract Development and Manufacturing Organization (CDMO) Market Analysis - Global Industry Size, Share, Trends, Opportunity & Forecast, 2019-2029F [Yahoo! Finance]
5/14
09:43 am
ctlt
Small Molecule Innovator API CDMO Research Report 2024: Global Market to Reach $47.14 Billion by 2030 driven by Increasing Demand for Small Molecule Drugs, and Surge in Clinical Trials [Yahoo! Finance]
Low
Report
Small Molecule Innovator API CDMO Research Report 2024: Global Market to Reach $47.14 Billion by 2030 driven by Increasing Demand for Small Molecule Drugs, and Surge in Clinical Trials [Yahoo! Finance]
5/13
12:49 pm
ctlt
Catalent's (CTLT) Latest Partnership to Boost Clinical Trials [Yahoo! Finance]
Low
Report
Catalent's (CTLT) Latest Partnership to Boost Clinical Trials [Yahoo! Finance]
5/13
09:02 am
ctlt
Ozempic Maker Novo Nordisk Plans Bond Sale to Fund Expansion [BNN Bloomberg (Canada)]
Low
Report
Ozempic Maker Novo Nordisk Plans Bond Sale to Fund Expansion [BNN Bloomberg (Canada)]
5/13
08:09 am
ctlt
New Drug Approvals and Their Contract Manufacture 2024 Report - NDA Drug and Vaccine Approvals and the Levels of Outsourcing Associated with NDA Sub Segments [Yahoo! Finance]
Low
Report
New Drug Approvals and Their Contract Manufacture 2024 Report - NDA Drug and Vaccine Approvals and the Levels of Outsourcing Associated with NDA Sub Segments [Yahoo! Finance]
5/13
03:01 am
ctlt
Catalent, Inc. (NYSE: CTLT) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Low
Report
Catalent, Inc. (NYSE: CTLT) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
5/9
02:42 pm
ctlt
Catalent (CTLT) Q3 Earnings Lag Estimates, Gross Margin Up [Yahoo! Finance]
Low
Report
Catalent (CTLT) Q3 Earnings Lag Estimates, Gross Margin Up [Yahoo! Finance]
5/8
09:39 pm
ctlt
Catalent (CTLT) Reports Q3 Loss, Misses Revenue Estimates [Yahoo! Finance]
Low
Report
Catalent (CTLT) Reports Q3 Loss, Misses Revenue Estimates [Yahoo! Finance]
5/8
04:39 pm
ctlt
Catalent, Inc. Reports Third Quarter Fiscal 2024 Results [Yahoo! Finance]
Low
Report
Catalent, Inc. Reports Third Quarter Fiscal 2024 Results [Yahoo! Finance]
5/8
04:15 pm
ctlt
Catalent, Inc. Reports Third Quarter Fiscal 2024 Results
Low
Report
Catalent, Inc. Reports Third Quarter Fiscal 2024 Results
5/8
11:11 am
ctlt
Siren Biotechnology and Catalent Enter Partnership for Manufacturing of AAV Gene Therapies for Cancer [Yahoo! Finance]
Neutral
Report
Siren Biotechnology and Catalent Enter Partnership for Manufacturing of AAV Gene Therapies for Cancer [Yahoo! Finance]
5/7
09:24 am
ctlt
Expansion of The Nutraceutical Industry Fueled by Technological Advancements and Product Innovation Accelerates the Global Nutraceutical CDMO Market; says TNR, The Niche Research [Yahoo! Finance]
Low
Report
Expansion of The Nutraceutical Industry Fueled by Technological Advancements and Product Innovation Accelerates the Global Nutraceutical CDMO Market; says TNR, The Niche Research [Yahoo! Finance]
5/5
02:32 am
ctlt
Catalent, Inc. (NYSE: CTLT) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Low
Report
Catalent, Inc. (NYSE: CTLT) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
5/3
11:00 am
ctlt
Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders of Catalent, Inc. (CTLT) Investigation
Neutral
Report
Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders of Catalent, Inc. (CTLT) Investigation
5/3
09:30 am
ctlt
Catalent, Novo Nordisk receive FTC request for more information [Seeking Alpha]
Low
Report
Catalent, Novo Nordisk receive FTC request for more information [Seeking Alpha]